UNLIMITED TURBO LONG - PFIZER INC | Real-time Euronext Paris 04:23:32 2024-05-29 EDT | ||
| 4.3 EUR | -0.92% |
|
| Current month | +128.42% | ||
| 1 month | +156.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 4.3 | -0.92% |
| 24-05-28 | 4.34 | -13.03% |
| 24-05-27 | 4.99 | +7.08% |
| 24-05-24 | 4.66 | -5.86% |
| 24-05-23 | 4.95 | -6.43% |
Real-time Euronext Paris
Last update May 29, 2024 at 04:23 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| 8L3MB | |
| ISIN | NLBNPNL2JEX5 |
| Date issued | 2023-10-17 |
| Strike | 23.85 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 7.4 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.89 € |
|---|---|
| Lowest since issue | 1.52 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.3
USD
Average target price
31.92
USD
Spread / Average Target
+12.78%
- Stock Market
- Certificates
- 8L3MB Certificat
